Cytodyn will win & will become a worldwide success! (My

New Post Public Reply Private Reply Replies (0) Message Board
Sunny3999
982
Cytodyn will win & will become a worldwide success!
(My personal assessment!)

After all the tireless efforts, for every life that is on the brink this Doctors

- CEO Dr. Nader Pourhassan (Cytodyn)
- Dr. Bruce Patterson, (IncelDx)
- Dr. Jack Lalezari (Crest Clinic SF),
- Dr. Harish Seethamraju (Montefiori Clinic NYC),
- Prof Dr. Yang (UCLA),
- now as well Dr. Jo (youtube) and there are joining more every day to fight for lives.

CEO Dr. Nader Pourhassan made clear with each conference, that they have kept this alive for humanity, for the life of the doomed and for us shareholders of Cytodyn not be diluted for less at it is worth for!!

The postponed publication of the findings on Covid-19 through the use of Vyrologix (Leronlimab) could not have been foreseen, the complexity behind it and the fundamental approach, probably require more time to study and understand the whole content - which has than has to be translated in a laymen word to easily understand what is behind of the "Once in a lifetime drug" that will safe the world for existing and future pandemic outbreaks.

Still, it was important to hold the Wall Street Reporter conference, why?

To commit everyone and future stockholders to it and to inform them about the discoveries and potential behind Cytodyn and Vyrologix.

With every conference there will be more listeners and at some point the time will come where the general public and those responsible, will no longer be able to close their eyes to the truth - because science will convince experts and actual unbelievers and the pressure from the public will be strong so there Vyrologix will be approved by EUA!

Cytodyn is about to show the world what weapon it has against deadly viruses like Covid-19, Mers, Cancer (at least 22 various), HIV, GHvD and many other diseases.

If the United States and those responsible do not wake up soon, other countries (Canada / UK) and companies manager from other BP countries will take partnership with Cytodyn and bring it to success (we all can hope it will not be China or a chinese BP at the end)!

This would allow the United States to take a general-purpose weapon out of its hand - that will not and should not happen! [/ b]

I suspect and hope in less than 10-15 days, Cytodyn will receive funding from organizations and the EUA approval.

The criminal shorters with their lies, false claims have blood on their hands and should be brought to justice - by the US judiciary personally!

They are responsible that it will take longer than expected, as CEO Nader Pourhassan said - if Cytodyn would get to double digits shareprice Cytodyn could raise money without a blink and less dilution to uplist on Nasdaq/NYSE - where the bigger funds and institutions are waiting with open arms to get a piece of this revolutionary drug and Cytodyn as company!

Patience is a virtue and if USA is what they preach for, than they should take action in all point written above!

Greetings from Germany and stay healthy!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Air Force Enlisted Village: Trailblazing Senior Care

Updated Category News Views 8

Changing the Senior Living Game for Military Families Out of all the fancy talk shows and slick productions, "All Access hosted by Andy Garcia" managed to hit a real nerve on the quiet, critical shifts happening in the senior living sector. They dug into how Air Force Enlisted Village in Shalimar is taking care of our military families' unsung heroes—the surviving...

Continue Reading
Regal Healthcare: Five Years of Founder-Friendly Valor

Updated Category News Views 66

Why Founder-Friendly Matters More Than Ever in Healthcare Well folks, in a year when everyone's tossing around terms like 'value-added' and 'strategic support', seeing Regal Healthcare Capital Partners snag slot number five straight on Inc.'s Founder-Friendly Investors list feels like catching a rare breed of fish twice. Seriously, these folks are stamping their forte as...

Continue Reading
Georgia-Pacific's $150M Bet on Bathroom Tissue Future

Updated Category News Views 32

Georgia-Pacific is throwing down a cool $150 million to jazz up its mill in Palatka, Florida. Yep, they're not just scrubbing the edges, but rebuilding one of the paper machines there—from the ground up. Why the fuss? Well, in the paper game, keeping your machines ahead of the pack means everything. In this case, it’s about ramping up for dear ol’ Angel Soft® bath...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 147

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
Yulin Dog Meat Ban: A Milestone in Animal Rights

Updated Category News Views 51

Shockwaves from Yulin: A Landmark Victory Out of the blue, the news from Yulin is stirring emotions worldwide. All dog slaughterhouses in Yulin, a city notorious for its gruesome dog meat festival, have been reportedly demolished. The city plans to impose a ban on dog meat, a radical shift unimaginable a decade ago. For animal rights advocates, it's an invigorating shot...

Continue Reading
Kong Joins Forces with ServiceNow for AI Governance

Updated Category News Views 185

Shaping the Future of Enterprise AI When it comes to AI governance, it's not just about flashy tech jargon; it's about ensuring that enterprises can tread carefully and confidently in the AI arena. Kong, the AI Connectivity Company, is making a significant move by teaming up with ServiceNow in what's been dubbed the ServiceNow Control Tower Alliance. This collaboration...

Continue Reading
Arctic Wolf Leads in AI SOC: A 2026 Game Changer

Updated Category News Views 0

Leading the Pack with AI-Powered Security In the world of cybersecurity, where every day feels like a battlefield, Arctic Wolf has clawed its way to the top spot in the Q4 2026 QKS SPARK Matrix™ for AI SOC Automation. This recognition doesn't just highlight their prowess in handling security operations; it underscores their relentless commitment to infusing AI...

Continue Reading
Domino’s Faces Legal Heat: Investors' Eyes On DPZ

Updated Category News Views 108

Domino's Pizza Under the Legal Microscope Picture this, folks: Domino's Pizza (NASDAQ: DPZ) is caught in a legal whirlwind that might give its shareholders a rollercoaster of a read in the coming weeks. On the docket is a serious probe led by Johnson Fistel, a law outfit with quite the reputation for defending shareholder interests. The focus? Whether certain hot shots at...

Continue Reading
KSHN Debuts THC Pouches for Smoke-Free Relief

Updated Category News Views 54

Rolling Out a New Chapter in Medical Cannabis In the world of medical marijuana, things are constantly evolving, always adapting. Now, here comes KSHN Pouch Co., dropping a fresh line of THC pouches across Pennsylvania with a bang. Powered by Terrapin, a veteran in the Commonwealth's medical marijuana scene, these pouches are stirring things up for patients looking for a...

Continue Reading
FirstLight Home Care Reaches 300 Locations Milestone

Updated Category News Views 59

FirstLight Celebrates a Major Milestone FirstLight Home Care just hit a big milestone, reaching a whopping 300 locations. That's not just a feather in their cap; it's a sign that their approach to senior care is resonating with communities across the map. The company is kicking off a celebration tour, cleverly dubbed the Best Days Tour, highlighting each step forward with...

Continue Reading

Top 5 Most Recently Viewed Articles

BCMGlobal Takes Charge of NFSC's Loan Servicing Evolution

Updated Category News Views 197

BCMGlobal's New Role in Advancing NFSC BCMGlobal has been appointed to strategically manage the National Financing Support Services Company (NFSC), elevating it to a leading independent loan servicer. This initiative aims to promote excellence in the sector. Supporting Saudi Arabia's Financial Vision The NFSC, established with the backing of the Saudi Real Estate...

Continue Reading
Breakthrough MRD Data from Myriad Genetics at Cancer Conference

Updated Category News Views 201

Innovative Insights into MRD Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent name in molecular diagnostics and precision medicine, is set to unveil exciting new clinical findings related to their Precise MRD test at a significant annual meeting dedicated to cancer research. Presentation Highlights During the conference, Dr. Chad Tang from The University of Texas...

Continue Reading
SBM Offshore's Recent Share Buyback Program: Key Insights

Updated Category News Views 119

SBM Offshore's Share Buyback Program Overview SBM Offshore has recently reported on its significant share repurchase program, valued at EUR130 million (approximately US$140 million), covering transactions made from November 21, 2024, to November 27, 2024. This initiative underscores the company’s commitment to enhancing shareholder value through systematic buybacks. Key...

Continue Reading
Investigation into Akero Therapeutics by Berger Montague PC

Updated Category News Views 165

Akero Therapeutics Under Investigation by Berger Montague Berger Montague PC, a respected law firm, recently brought to attention an ongoing investigation into the practices of Akero Therapeutics, Inc. The investigation focuses on potential breaches of fiduciary duties and violations of federal securities laws by Akero’s Board of Directors, which has crucial...

Continue Reading
Nkarta's Upcoming Interactive Session: What to Expect?

Updated Category News Views 127

Nkarta to Engage with Investors in H.C. Wainwright Series Nkarta, Inc. (NASDAQ: NKTX), a pioneering clinical-stage biopharmaceutical firm dedicated to creating innovative engineered natural killer (NK) cell therapies, recently announced its notable role in the H.C. Wainwright "HCW@Home" Series. This virtual series will allow investors and interested parties to gain deeper...

Continue Reading